Guidance

COVID-19 treatments: making a proposal for clinical trials

Guidance for innovators looking to propose coronavirus (COVID-19) treatments for testing in UK clinical trials.

From:
Department of Health and Social Care
Published
17 August 2020
Last updated
16 December 2020 — See all updates

This publication was withdrawn on

This page has been withdrawn because it’s no longer current. See the COVID-19 Antivirals and Therapeutics Taskforce page for information on the provision of treatments for coronavirus (COVID-19) in the UK.

Documents

[Withdrawn] Guidance: making a proposal for COVID-19 therapeutics clinical trials

HTML

[Withdrawn] Proposal form for entry to COVID-19 therapeutics clinical trials

https://podio.com/webforms/24960299/1831874

Details

This guidance gives information on:

  • the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP)
  • how innovators can propose new treatments for inclusion in the RECOVERY+, REMAP-CAP, PRINCIPLE or AGILE trials

Updates to this page

Published 17 August 2020
Last updated 16 December 2020 show all updates

  1. Updated guidance to include information on REMAP-CAP, PRINCIPLE and AGILE trials.

  2. First published.

Sign up for emails or print this page

Related content